STOCKSCREENR

0JDK.L

LSE

Iovance Biotherapeutics, Inc.

$3.38+0.10(+3.07%)Mkt Cap: $1.21B

Key Stats

Market Cap

$1.21B

P/E Ratio

-1.47

EPS

$-2.30

Dividend Yield

0.00%

52-Week Range

$3.22 — $18.31

Volume

33

Avg Volume

53.27K

Beta

0.76

Price Alerts for 0JDK.L

Get alerted when 0JDK.L hits your target price.

$

Free — enter your email to get started

Valuation

P/E (TTM)

-1.47

Forward P/E

—

PEG Ratio

-0.20

P/S (TTM)

4.44

P/B (TTM)

2.06

P/FCF

—

EV/EBITDA

—

EV/Sales

—

Financial Health

ROE (TTM)

-0.55%

ROA (TTM)

-0.43%

ROIC

—

Gross Margin

0.97%

Operating Margin

-1.53%

Net Margin

—

Debt/Equity

0.07

Current Ratio

3.20

Growth

EPS Growth (YoY)

—

Revenue Growth (YoY)

—

EPS Growth (3Y)

+0.15%

EPS Growth (5Y)

+0.02%

Sales Growth (3Y)

+45.66%

Sales Growth (5Y)

+27.40%

EPS Est (This Year)

$-0.59

EPS Est (Next Year)

$-0.22

Dividends

Dividend Yield

—

Annual Dividend

—

Payout Ratio

—

Frequency

—

Ex-Dividend Date

—

Cash/Share

$0.73

Ownership

Institutional %

—

Inst. Net Change

—

Insider Net Shares (90d)

—

Outstanding Shares

331.69M

Float

338.65M

Free Float %

102.10%

About

Sector

Healthcare

Industry

Medical - Pharmaceuticals

Country

US

Exchange

LSE

IPO Date

2018-01-29

Employees

838

CEO

Frederick G. Vogt

Index Membership

—

Website

https://www.iovance.com

Iovance Biotherapeutics, Inc. (0JDK.L) is a healthcare company in the medical - pharmaceuticals industry listed on the LSE. With a market capitalization of $1.21B, a P/E ratio of -1.47, 0JDK.L is tracked by stockscreenr alongside 25,000+ other tickers. Use the free stock screener to compare 0JDK.L against other stocks using dozens of fundamental and technical filters.

Similar Stocks

0RU5.L

Oncoinvent ASA

$49.50

+3.13%

$1.94B

ATAI

Atai Beckley N.V

$4.16

+0.97%

$784.68M

0QND.L

Bachem Holding AG

$70.06

+2.29%

$5.24B

0L35.L

Sarepta Therapeutics, Inc.

$21.09

+2.59%

$2.11B

0IMT.L

Photocure ASA

$65.10

-4.41%

$1.73B

0QLN.L

Tecan Group AG

$117.70

+1.90%

$1.48B

Frequently Asked Questions

What is Iovance Biotherapeutics, Inc.'s P/E ratio?

Iovance Biotherapeutics, Inc. (0JDK.L) has a trailing twelve-month (TTM) P/E ratio of -1.47. This is below the market average, which may suggest the stock is undervalued or has lower growth expectations. The P/E ratio measures how much investors are willing to pay per dollar of earnings.

Does Iovance Biotherapeutics, Inc. pay a dividend?

No, Iovance Biotherapeutics, Inc. (0JDK.L) does not currently pay a regular dividend. The company may be reinvesting profits into growth, research, or debt reduction instead of returning cash to shareholders through dividends.

What is Iovance Biotherapeutics, Inc.'s market cap?

Iovance Biotherapeutics, Inc. (0JDK.L) has a market capitalization of $1.21 billion, classifying it as a small-cap company. Market cap is calculated by multiplying the current share price by the total number of outstanding shares.